BANK VONTOBEL/PUT/NOVO NORDISK ADR B/105/0.1/20.09.24 Share Price

Warrant

DE000VM30971

Delayed Deutsche Boerse AG 09:23:41 02/07/2024 BST
0.023 EUR +35.29% Intraday chart for BANK VONTOBEL/PUT/NOVO NORDISK ADR B/105/0.1/20.09.24
Current month-29.17%
1 month-78.21%
Date Price Change
02/07/24 0.023 +35.29%
01/07/24 0.017 -29.17%
28/06/24 0.024 -22.58%
27/06/24 0.031 -6.06%
26/06/24 0.033 +3.13%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 09:23 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VM3097
ISINDE000VM30971
Date issued 16/10/2023
Strike 105 $
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 1.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.68
Lowest since issue 0.017
Delta-0.03x
Omega 13.30
Premium28x
Gearing484.53x
Moneyness 0.7220
Difference Strike -40.42 $
Difference Strike %-38.50%
Spread 0.01
Spread %30.30%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,005 DKK
Average target price
950.4 DKK
Spread / Average Target
-5.39%
Consensus